In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Leadership

Set Alert for Leadership

David Or Goliath: Where Is Innovation Winning Through?

With both a big pharma and biotech leadership perspective, David Meeker talks to In Vivo about how smaller firms can more easily fly solo in drug development, challenges effecting the innovative drug development sector in 2019 and the partnering environment for cell and gene therapy companies. 

Leadership Regenerative Medicine BioPharmaceutical
Advertisement

Latest From Leadership

Execs On The Move, August 2019

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership

C-Suite Snippets: Medtech Leaders

In case you missed it: catch up with snippets from interviews published by In Vivo this week. 

Business Strategies Medical Device

MedTech Forum 2019: Building Growth In The Outcomes Era

The European MedTech Forum’s CEO panel set out to address high-level global, long-range issues, but from the start it got log jammed in regulatory issues. Not in the script perhaps, but wholly understandable, as new EU regulations will have huge strategic importance for how companies do business – and in the case of start-ups, if they can continue to do business.

Business Strategies Commercial

MedTech Forum 2019: The Future Is Here But Industry Still Needs A Long-Term Vision

In a world where national economies are beset by conflicting spending priorities, health care is oftentimes too low on the agenda, health care observers say. One of these is Boston Scientific senior vice-president Eric Thépaut, who understands the dilemmas, but says that health care will soon force its way up the priority list. He has advice for future-ready medtech innovators.

Leadership Medical Device

Execs On The Move, July 2019

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership

Leading From The Lab: MIT’s Robert Langer On The Converging Science Of Drugs, Devices And Delivery

Ten years after our first encounter with MIT’s Robert Langer, In Vivo sits down with the polymath professor – arguably the most inventive and prolific life scientist of his generation – to identify key challenges in medicine. 

Business Strategies StartUps and SMEs
See All
UsernamePublicRestriction

Register